10-Q: TerrAscend Corp. Reports Q1 2024 Results, Revenue Up 16% Year-Over-Year
Quarterly Report
TerrAscend Corp. saw a 16% increase in revenue year-over-year in the first quarter of 2024, driven by growth in Maryland and wholesale channels, despite a net loss of $14.85 million.
Summary
- TerrAscend Corp. reported a net revenue of $80.63 million for the three months ended March 31, 2024, compared to $69.39 million for the same period in 2023, representing a 16% increase.
- The company's cost of sales increased to $41.90 million from $35.49 million year-over-year.
- The company experienced a net loss from continuing operations of $14.85 million, compared to a net loss of $19.17 million in the prior year.
- The company's operating expenses totaled $32.66 million, including $28.00 million in general and administrative expenses.
- The company's cash and cash equivalents stood at $22.66 million as of March 31, 2024.
- The company's total assets were $655.53 million, and total liabilities were $423.43 million as of March 31, 2024.
- The company's working capital was negative $101.46 million as of March 31, 2024.
- The company's adjusted EBITDA from continuing operations was $16.23 million for the quarter.
Sentiment
Score: 4
Explanation: The document presents mixed results with strong revenue growth offset by significant net losses and concerns about the company's ability to continue as a going concern. The company's debt and liquidity issues are also concerning.
Positives
- Revenue increased by 16% year-over-year, indicating strong sales growth.
- Wholesale revenue doubled in New Jersey and increased by 80% in Pennsylvania.
- The company's adjusted EBITDA from continuing operations was $16.23 million, showing improved profitability.
- The company completed strategic acquisitions in California, consolidating its operations.
- The company made prepayments on the Ilera Term Loan, reducing debt.
Negatives
- The company reported a net loss of $14.85 million from continuing operations.
- The company's working capital is negative, indicating potential liquidity issues.
- The company's current liabilities exceed its current assets, raising concerns about its ability to meet short-term obligations.
- The company recorded an impairment of property and equipment of $2.438 million due to the wind-down of one of its California dispensaries.
- The company experienced retail declines in New Jersey and Michigan.
Risks
- The company's ability to continue as a going concern is in doubt due to its accumulated deficit and negative working capital.
- The company may need to refinance its maturing debt or access additional capital to fund operations.
- The company is subject to risks related to federal and state laws regarding cannabis operations in the United States.
- The company faces competition in the cannabis industry.
- The company's tax positions are under review by the IRS, which could lead to increased scrutiny or audits.
- The company is involved in legal proceedings, including a lawsuit against Pure X, LLC.
Future Outlook
The company expects to fund future capital requirements through cash from operations, market offerings, additional debt, sale of real property, sale leaseback transactions, and exercise of options and warrants. The company also anticipates improved cash flow growth from its operations, particularly in New Jersey and Maryland.
Management Comments
- Management believes that the company's going concern concern is mitigated by steps it has taken, or intends to take to improve its operations and cash position.
- Management believes that Adjusted EBITDA from continuing operations is a useful performance measure to assess the performance of the Company as it provides more meaningful ongoing operating results by excluding the effects of expenses that are not reflective of the Company's underlying business performance and other one-time or non-recurring expenses.
Industry Context
The cannabis industry is subject to evolving regulations and market conditions. TerrAscend's performance is influenced by the legalization of cannabis in various states and the competitive landscape. The company's expansion into new markets and its focus on both medical and adult-use cannabis are aligned with industry trends.
Comparison to Industry Standards
- TerrAscend's revenue growth of 16% year-over-year is a positive sign, but it is important to compare this to the growth rates of other multi-state operators (MSOs) in the cannabis industry such as Curaleaf, Green Thumb Industries, and Trulieve.
- The company's negative working capital and net loss are concerning and should be compared to the financial health of its peers.
- The company's adjusted EBITDA of $16.23 million is a positive indicator, but it is important to assess its profitability relative to other MSOs.
- The company's strategic acquisitions in California are similar to the expansion strategies of other MSOs, but the success of these acquisitions will depend on integration and market performance.
- The company's debt levels and the need for additional capital are common challenges in the cannabis industry, and it is important to compare TerrAscend's debt structure and financing strategies to those of its competitors.
Legal Proceedings
- AEY Capital LLC, a subsidiary of the company, filed a lawsuit against Pure X, LLC seeking damages of $14.969 million for breach of contract and other claims.
Related Party Transactions
- A small number of related persons, which consisted of key management of the Company, participated in the Ilera term loan, which makes up $149 and $159 of the total loan principal balance at March 31, 2024 and December 31, 2023, respectively.
Stakeholder Impact
- Shareholders are impacted by the net loss and the uncertainty about the company's ability to continue as a going concern.
- Employees are impacted by the company's financial performance and potential restructuring.
- Customers are impacted by the company's ability to provide products and services.
- Creditors are impacted by the company's debt obligations and ability to repay.
- Suppliers are impacted by the company's ability to pay for goods and services.
Next Steps
- The company will need to address its negative working capital and debt obligations.
- The company will need to continue to improve its cash flow from operations.
- The company will need to monitor the performance of its recent acquisitions.
- The company will need to manage its tax positions and legal proceedings.
Key Dates
| Date | Description |
|---|---|
| March 7, 2017 | TerrAscend Corp. was incorporated under the Business Corporations Act (Ontario). |
| May 3, 2017 | The common shares commenced trading on the Canadian Securities Exchange (CSE). |
| October 22, 2018 | The common shares commenced trading on OTCQX under the ticker symbol 'TRSSF'. |
| December 18, 2020 | WDB Holding PA entered into a senior secured term loan with a syndicate of lenders (Ilera Term Loan). |
| March 10, 2022 | The company completed the acquisition of Gage Growth. |
| October 11, 2022 | Subsidiaries of TerrAscend entered into a loan agreement with Pelorus Fund REIT, LLC (Pelorus Term Loan). |
| April 18, 2023 | TerrAscend and the Issuer entered into a protection agreement. |
| June 26, 2023 | The company closed on a commercial loan with Stearns Bank (Stearns Loan). |
| July 4, 2023 | The common shares commenced trading on the Toronto Stock Exchange (TSX) under the ticker symbol 'TSND'. |
| July 6, 2023 | The ticker symbol on OTCQX was changed to 'TSNDF'. |
| August 9, 2023 | AEY Capital LLC filed a lawsuit against Pure X, LLC. |
| January 2, 2024 | The company made a prepayment of the Ilera Term Loan of $4.8 million. |
| January 15, 2024 | The company paid off the IHC Real Estate LP promissory note with a final payment of $5 million. |
| January 19, 2024 | The company acquired the remaining equity in State Flower and three Apothecarium dispensaries in California. |
| March 31, 2024 | End of the reporting period for the first quarter of 2024. |
| April 30, 2024 | The company made a prepayment of the Ilera Term Loan of $3.2 million. |
| May 8, 2024 | The registrant had 291,507,430 common shares outstanding. |
| May 9, 2024 | Date of the report. |
Keywords
cannabis, revenue, EBITDA, net loss, acquisitions, debt, wholesale, retail, Maryland, New Jersey, Pennsylvania, financial results, going concern, liquidity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.